- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 17
Skylo escapes stealth with $116m
SoftBank has led a $103m series B round for the IoT network and hub developer, a spinout of Stanford, that made up one of two rounds it has raised.
Jan 21, 2020Inscripta cribs $125m in series D round
CU Boulder spinout Inscripta has now accumulated more than $259m from investors including Institut Mérieux, and will use the capital to further expand its genome engineering platform.
Dec 18, 2019CureFit starts training for $100m round
Temasek could reportedly invest in CureFit at a valuation of $800m, three years after UC-RNT Fund supplied $25m to the wellness services provider.
Dec 3, 2019PsiQuantum swings $230m
University of Bristol-founded PsiQuantum has reportedly scooped funding from backers including an Andy Rubin fund as it looks to develop silicon-powered quantum computers.
Nov 19, 2019eGenesis brings about $100m series B
Harvard's xenotransplantation technology developer eGenesis has raised a $100m in its series B round.
Nov 8, 2019Databricks builds $400m series F
Andreessen Horowitz has led a $400m round for the data preparation software provider based on UC Berkeley research, more than doubling its valuation to $6.2bn in eight months.
Oct 23, 2019CMR Surgical completes $240m series C operation
Cambridge Innovation Capital has returned a second time to back a $240m series C for CMR Surgical, helping bring the surgical robotics company's total funding to $386m.
Sep 18, 2019Trifacta wrangles $100m
Trifacta, co-founded by Stanford and UC Berkeley researchers, has attracted nearly a dozen investors for a round that brought its total funding to $224m.
Sep 13, 2019CAS helps GKHT source $154m
Cash Capital has contributed to a a series C round for medical supplies provider GKHT, established as an affiliate of the Chinese Academy of Sciences-owned Osic Holding Group.
Sep 9, 2019Passage Bio packs in another $110m
University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.
Sep 5, 2019
About us
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.